1-20 of 40
Tae-Min Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT127: Trial in progress: A phase II, open-label, multicenter study of capivasertib, a potent, oral pan-AKT inhibitor in patients with relapsed or refractory B-cell non-hodgkin lymphoma (CAPITAL)

Michael Wang, Ho-Jin Shin, Alex F. Herrera, Moshe Levy, Wong Seog Kim, Tae Min Kim, Jin Seok Kim, Dok Hyun Yoon, Vincent Ribrag, Miguel Canales, John Radford, Dima El-Sharkawi, Brandy Hemmer, Richa Manwani, Veerendra Munugalavadla, Robert Chen, Andrew Mortlock, Alessandra Forcina, Franck Morschhauser
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT127.
DOI: https://doi.org/10.1158/1538-7445.AM2022-CT127
Published: 15 June 2022
View article
Journal Articles

Abstract CT037: Canakinumab in combination with first-line (1L) pembrolizumab plus chemotherapy for advanced non-small cell lung cancer (aNSCLC): Results from the CANOPY-1 phase 3 trial

Daniel S. Tan, Enriqueta Felip, Gilberto Castro, Benjamin J. Solomon, Alastair Greystoke, Byoungchul Cho, Manuel Cobo, Tae Min Kim, Sandip Ganguly, Enric Carcereny, Luis Paz-Ares, Jaafar Bennouna, Marina Garassino, Michael Schenker, Sang-We Kim, Bijoyesh Mookerje, Vanessa Q. Passos, Stephanie Deudon, Bharani Dharan, Yuanbo Song, Rafael Caparica, Bruce E. Johnson
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT037.
DOI: https://doi.org/10.1158/1538-7445.AM2022-CT037
Published: 15 June 2022
View article
Journal Articles

Abstract 5477: Compound A, a fourth-generation allosteric inhibitor, a potent and highly selective EGFR with L858R activating and C797S resistance mutations for the treatment of NSCLC

Yeji Byeon, Seung Hee Jung, Daseul Yoon, Seock Yong Kang, Jiyeon Park, Hyeim Jo, Seong-Il Choi, Somyi Park, Seung-chul Lee, Yang Hun Tae, Tae Min Kim, Sung-Yup Cho, Soyeon Kim, Donghyun Ko, Dong-Kyu Kim, Dong-Wan Kim
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5477.
DOI: https://doi.org/10.1158/1538-7445.AM2022-5477
Published: 15 June 2022
View article
Journal Articles

Abstract CT025: Dabrafenib plus trametinib in BRAF V600E-mutant high-grade (HGG) and low-grade glioma (LGG)

Vivek Subbiah, Alexander Stein, Martin van den Bent, Antje Wick, Filip Y. de Vos, Nikolas von Bubnoff, Myra E. van Linde, Albert Lai, Gerald W. Prager, Mario Campone, Angelica Fasolo, Jose A. Lopez-Martin, Tae Min Kim, Ralf-Dieter Hofheinz, Jean-Yves Blay, Daniel C. Cho, Anas Gazzah, Damien Pouessel, Jeffrey Yachnin, Aislyn Boran, Paul Burgess, Palanichamy Ilankumaran, Eduard Gasal, Patrick Y. Wen
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): CT025.
DOI: https://doi.org/10.1158/1538-7445.AM2021-CT025
Published: 01 July 2021
View article
Journal Articles

Abstract CT214: CANOPY-1: Safety run-in results from phase (ph) 3 study of canakinumab (CAN) or placebo (PBO) in combination (comb) with pembrolizumab (PEM) plus platinum-based doublet chemotherapy (Ctx) as 1st line therapy in patients (pts) with advanced or metastatic NSCLC

Bruce E. Johnson, Tae Min Kim, T. Jeroen N. Hiltermann, Fabrice Barlesi, Christian Grohe, Yasushi Goto, Orvar Gunnarsson, Tobias Overbeck, Noemi Reguart, Martin Wermke, Gilberto Castro Castro, Enriqueta Felip, Alastair Greystoke, Benjamin J. Solomon, Stephanie Deudon, Anne-Laure Louveau, Vanessa Passos, Daniel SW Tan
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): CT214.
DOI: https://doi.org/10.1158/1538-7445.AM2020-CT214
Published: 15 August 2020
View article
Journal Articles

Abstract 4981: Comprehensive analysis of immune phenotypes identifies CD73+ CD163high macrophages as a prognostic biomarker in lung adenocarcinoma

Jae-Hwan Kim, Tae-Min Kim, Sung-Gu Her, Kyoung-Ho Pyo, Jeong- Oh Kim, Beung-Chul Ahn, Byoung Chul Cho, Jin Hyoung Kang
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 4981.
DOI: https://doi.org/10.1158/1538-7445.AM2020-4981
Published: 15 August 2020
View article
Journal Articles

Abstract 2030: Inhibiting the GAS6/AXL axis suppresses tumor progression by blocking the interaction between cancer-associated fibroblasts and cancer cells in gastric carcinoma

Dagyoeng Lee, Jongsu Woo, Cheong A Bae, In-Hye Ham, Hye Jung Oh, Sang-Yong Son, Sang-Uk Han, Tae-Min Kim, Jung Hwan Yoon, Won Sang Park, Hoon Hur
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 2030.
DOI: https://doi.org/10.1158/1538-7445.AM2019-2030
Published: 01 July 2019
View article
Journal Articles

Abstract 1079: Prognostic role of tumor microenvironment in correlation with CD8+ T cells in TCGA pan-cancer

Shin Hye Yoo, Changhee Park, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 1079.
DOI: https://doi.org/10.1158/1538-7445.AM2019-1079
Published: 01 July 2019
View article
Journal Articles

Abstract 1498: Methylation landscape of cancers associated with immunogenicity

Changhee Park, Kyeonghun Jeong, Joon-Hyeong Park, Jeong Mo Bae, Kwangsoo Kim, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Tae Min Kim, Yoon Kyung Jeon, Dong-Wan Kim, Gyeong Hoon Kang, Doo Hyun Chung, Dae Seog Heo
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 1498.
DOI: https://doi.org/10.1158/1538-7445.AM2019-1498
Published: 01 July 2019
View article
Journal Articles

Abstract 3032: Acquired resistance to osimertinib in patients with de novo EGFRT790M-positive non-small cell lung cancer (NSCLC)

Ha-Ram Park, Yusoo Lee, Tae Min Kim, Soyeon Kim, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Yoon Kyung Jeon, Dong-Wan Kim, Dae Seog Heo
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3032.
DOI: https://doi.org/10.1158/1538-7445.AM2019-3032
Published: 01 July 2019
View article
Journal Articles

Abstract 5201: Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: Therapeutic implications for immune checkpoint inhibitors

Ryul Kim, Bhumsuk Keam, Sehui Kim, Miso Kim, Se Hyun Kim, Jin Wook Kim, Yu Jung Kim, Tae Min Kim, Yoon Kyung Jeon, Dong-Wan Kim, Doo Hyun Chung, Jong Seok Lee, Dae Seog Heo
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 5201.
DOI: https://doi.org/10.1158/1538-7445.AM2018-5201
Published: 01 July 2018
View article
Journal Articles

Abstract 2855: Identification of optimal treatment sequence and acquired resistance mechanisms of ALK inhibitors using EML4-ALK transgenic mouse model

Kyoung-Ho Pyo, Lim Sun Min, Jae Hwan Kim, Ji Min Lee, Ha Ni Jo, Jae Soek Cho, Mi-Ran Yun, Sung Eun Kim, Hye Ryun Kim, Chun-Feng Xin, Tae-Min Kim, Byoung Chul Cho
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2855.
DOI: https://doi.org/10.1158/1538-7445.AM2018-2855
Published: 01 July 2018
View article
Journal Articles

Abstract 3990: Clinicopathologic findings and in vitro efficacy of MYC-targeting agentsin NUT midline carcinoma

Soyeon Kim, Minsun Jung, Heae Surng Park, Sun Och Yoon, Soon Won Hong, Weon-Seo Park, Bhumsuk Keam, Hyun Jik Kim, Dong-Wan Kim, Young Tae Kim, Dae Seong Heo, Tae Min Kim, Yoon Kyung Jeon
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 3990.
DOI: https://doi.org/10.1158/1538-7445.AM2018-3990
Published: 01 July 2018
View article
Journal Articles

Abstract 3883: Transcriptome analysis reveals mitochondrial gene signature upregulation in gastric cancers expressing the stem cell marker CD133

Han Hong Lee, Yoon Ho Ko, Tae-Min Kim, Won-Sang Park
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 3883.
DOI: https://doi.org/10.1158/1538-7445.AM2017-3883
Published: 01 July 2017
View article
Journal Articles

Abstract 652: PD-L1 and MHC class 1 expression levels are modulated by MEK inhibition on head and neck squamous cell carcinoma

Seong-Ho Kang, Bhumsuk Keam, Soyeon Kim, Miso Kim, Yong-Oon Ahn, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 652.
DOI: https://doi.org/10.1158/1538-7445.AM2017-652
Published: 01 July 2017
View article
Journal Articles

Abstract 3157: Osimertinib (AZD9291) is effective against NSCLC cells harboring EGFR exon 20 insertion mutations

Yusoo Lee, Tae Min Kim, Dong-Wan Kim, Yong-Oon Ahn, Soyeon Kim, Bhumsuk Keam, Miso Kim, Dae Seog Heo
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 3157.
DOI: https://doi.org/10.1158/1538-7445.AM2017-3157
Published: 01 July 2017
View article
Journal Articles

Abstract 4029: MEK pathway inhibition upregulates PD-L1 and MHC class I expression levels in head and neck squamous cell carcinoma

Seong-Ho Kang, Bhumsuk Keam, Soyeon Kim, Miso Kim, Yong-Oon Ahn, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4029.
DOI: https://doi.org/10.1158/1538-7445.AM2016-4029
Published: 15 July 2016
View article
Journal Articles

Abstract 5194: A Mouse-Human co-clinical trial with patient-derived xenograft (PDX) models demonstrates a predictive signature for dovitinib (TKI258), an FGFR and VEGFR inhibitor,in lung squamous cell carcinomalung cancer (LSCC)

Hye Ryun Kim, Han Na Kang, Sung Moo Kim, Hwan Kim, Kyoung-Ho Pyo, Myung-Ju Ahn, Tae Min Kim, Byoung Chul Cho
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 5194.
DOI: https://doi.org/10.1158/1538-7445.AM2016-5194
Published: 15 July 2016
View article
Journal Articles

Abstract 2416: Activity of sunitinib for lung adenocarcinoma with RET rearrangement

June-Koo Lee, Soyeon Kim, Jong-Yeon Shin, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Jong-Il Kim, Dae Seog Heo, Jeong-Sun Seo, Se-Hoon Lee
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 2416.
DOI: https://doi.org/10.1158/1538-7445.AM2015-2416
Published: 01 August 2015
View article
Journal Articles

Abstract 608: Identification of genomic alteration which affects resistance to induction chemotherapy in patients with locally-advanced head and neck squamous cell carcinoma

Chan-Young Ock, Bongjun Son, Seungyoun Lee, Jaewoo Moon, Sehui Kim, Bhumsuk Keam, Tae Min Kim, Yoon Kyung Jeon, Se-Hoon Lee, Dong-Wan Kim, Dae Seog Heo
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 608.
DOI: https://doi.org/10.1158/1538-7445.AM2015-608
Published: 01 August 2015
View article